Table 1.

Unmet needs in pediatric patients with asthma

Lack of clinical efficacy and safety evidence of biologics in patients <6 years

Limited availability of non‐steroid‐based alternative therapies

Lack of available therapies for children with severe asthma

Difficult diagnosis in children

Scarcity of studies on allergen immunotherapy in children

Limited access to specialist pediatric asthma care in some countries

No uniform definition of pediatric asthma or pediatric asthma control

Inadequate pediatric focus in current clinical practice guidelines

Lack of data on asthma endotypes/phenotypes

Lack of well‐defined pediatric treatable traits

Lack of molecular studies

Lack of data on personalized treatment strategies based on a phenotype (endotype) approach

Lack of treatment options for comorbidities